Bacterin Issued Patent for Method to Produce Demineralized Bone Matrix

Bacterin International Holdings

today announced that the United States Patent and Trademark Office has issued US Patent No. 8,574,825 entitled “Process for Demineralization of Bone Matrix with Preservation of Natural Growth Factors.” The issued claims in the patent are for a method to produce a demineralized cancellous bone matrix, such as Bacterin's OsteoSponge® product line. Bacterin has a pending divisional application in the United States to pursue protection on other aspects of its bone demineralization technology and is pursuing protection on related applications in Canada, Europe, and Korea. Gregory Juda, Bacterin's CSO, commented “We are pleased